NLRP6, decreased in gastric cancer, suppresses tumorigenicity of gastric cancer cells
Authors Wang Q, Wang C, Chen J
Received 7 August 2018
Accepted for publication 11 October 2018
Published 27 November 2018 Volume 2018:10 Pages 6431—6444
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Chien-Feng Li
Qingqing Wang,1 Chunmei Wang,2,3 Jinlian Chen2,3
1Department of Gastroenterology, Fengxian Hospital, Anhui University of Science and Technology, Shanghai 201499, China; 2Department of Gastroenterology, Fengxian Hospital, Southern Medical University, Shanghai 201499, China; 3Department of Gastroenterology, Shanghai Sixth People’s Hospital (South), Shanghai Jiaotong University, Shanghai 201499, China
Background: Helicobacter pylori (H. pylori) infection has been regarded as a main risk factor for gastric cancer. Nod-like receptor pyrin domain-containing protein 6 (NLRP6), a component of inflammasome, has been linked to colorectal tumorigenesis. Here, we aimed to evaluate NLRP6 expression profile and functions in gastric cancer.
Materials and methods: We examined NLRP6 expression in gastric cancer and adjacent normal gastric tissues. The biological functions and mechanism of NLRP6 overexpression in gastric cancer cells were investigated.
Results: Downregulated NLRP6 expression in human gastric cancer significantly correlated with H. pylori infection, tumor size, TNM stage, lymph node metastasis, and overall survival. NLRP6 overexpression in gastric cancer cells led to a significant decrease in cell proliferation, migration, and invasion, as well as a notable increase in cell apoptosis, whereas NLRP6 knockdown had opposing effects. In addition, NLRP6 overexpression significantly repressed STAT3 phosphorylation and the transcription of its target genes, Bcl-2 and MMP-2. Moreover, forkhead box O3 (FOXO3), a transcription factor regulated by H. pylori, was demonstrated as an upstream regulator of NLRP6 transcription.
Conclusion: Our study may provide insight into the understanding of NLRP6 as a tumor suppressor and implicate the potential application of NLRP6 for gastric cancer treatment.
Keywords: NLRP6, H. pylori, cell proliferation, cell apoptosis, gastric cancer
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]